‘This is a big deal’: Health Canada approves 1st drug to slow Alzheimer’s disease – National
For the first time, Health Canada has approved a new drug that can slow the progression of Alzheimer’s…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…